Image

A Random Controlled Trial of Home-based Digital Therapy for Treating ADHD in Children

A Random Controlled Trial of Home-based Digital Therapy for Treating ADHD in Children

Recruiting
7-11 years
All
Phase N/A

Powered by AI

Overview

Explore the interventional effects of neurofeedback games on school-aged children with mild to moderate ADHD, with the aim of providing evidence-based new methods for intervening in the core symptoms of ADHD in children.

Description

  1. Research Title

A Randomized Controlled Study on the Efficacy of Home-Based Digital Therapy with Brain-Controlled Games for School-Aged Children with Attention Deficit Hyperactivity Disorder. 2. Research Objective

To explore the efficacy of brain-controlled games as an intervention for school-aged children with mild to moderate ADHD, with the aim of providing a new evidence-based method to intervene in the core symptoms of ADHD. 3. Study Design

Randomized Controlled Study.
4. Total Cases
5. Case Selection

Inclusion Criteria: Children aged 7 years, 0 months to 11 years, 11 months who are diagnosed by a physician with at least the rank of attending physician in pediatric psychiatry as meeting the diagnostic criteria for ADHD according to the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition), have a full-scale Wechsler IQ higher than 85, and are outpatient children with ADHD who have not received any intervention (newly diagnosed within the last month or have not taken medication for at least 4 weeks). Informed consent will be obtained from the patient/guardian and from participants aged 8 years and older. 6. Exclusion Criteria

Exclusion criteria include:

  1. Auditory or visual diseases or disorders.
  2. Inability to use the software, such as color blindness, or hand function defects or disabilities.
  3. Comorbidities with other neurodevelopmental disorders such as oppositional defiant disorder, autism spectrum disorder, pervasive developmental disorder, Tourette's syndrome, etc.
  4. Patients with other mental illnesses such as organic mental disorders, schizophrenia, bipolar disorder, or depressive disorders.
  5. Attention deficit disorder caused by organic diseases of the nervous system or other organic diseases.
  6. Previous history of ineffective regular ADHD medication as prescribed by a doctor.
  7. Past or present game addiction.
  8. Previous similar brain-controlled game interventions like Neurotest.
  9. Previous physical therapy such as magnetic stimulation. 7. Treatment Protocol

Home-based digital therapy with ADHD brain-controlled games. 8. Efficacy Assessment

Primary Outcome Measure: ADHD SNAP-IV subscale scores (Inattention/Hyperactivity-Impulsivity).

Secondary Outcome Measure: Executive Function (BRIEF) questionnaire scores. 9. Statistical Methods

The differences in evaluation results between the intervention group and the control group will be analyzed using a repeated measures analysis of variance from a general linear model. Missing data will be handled using the Last Observation Carried Forward (LOCF) method. The study will control for inter-group bias through measures such as random assignment, consistent training of evaluators, and blind evaluation where the evaluators are unaware of the subjects' treatment status.

Eligibility

Inclusion Criteria:

  • Children aged 7 years 0 months to 11 years 11 months
  • Clinical diagnosis of ADHD made by a child psychiatrist at the attending level or above
  • Wechsler Intelligence Scale for Children (WISC) Full Scale IQ (FSIQ) above 85
  • Children who have been diagnosed with ADHD but have not received any intervention (newly diagnosed within the last month or not having taken medication for at least 4 weeks)
  • Informed consent must be obtained from the patient/guardian and from participants

Exclusion Criteria:

  • Auditory or visual illness or disorder
  • Inability to use software (e.g., color blindness, impaired hand function, or disability)
  • Comorbid oppositional defiant disorder, autism spectrum disorder, pervasive developmental disorder, tic disorders, or other neurodevelopmental disorders
  • Other mental illnesses such as organic mental disorders, schizophrenia, bipolar disorder, or depressive disorders
  • Attention deficit disorder caused by organic neurological diseases or other organic diseases
  • Previous regular ADHD medication use as prescribed by a doctor, but without efficacy
  • Past or present gaming addiction
  • Previous neurofeedback-like "brain control game" interventions
  • Previous physical therapy such as magnetic stimulation.

Study details
    Attention Deficit Hyperactivity Disorder (ADHD)

NCT07552909

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

13 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.